Unknown

Dataset Information

0

Moving Breast Cancer Therapy up a Notch.


ABSTRACT: Breast cancer is the second most common malignancy, worldwide. Treatment decisions are based on tumor stage, histological subtype, and receptor expression and include combinations of surgery, radiotherapy, and systemic treatment. These, together with earlier diagnosis, have resulted in increased survival. However, initial treatment efficacy cannot be guaranteed upfront, and these treatments may come with (long-term) serious adverse effects, negatively affecting a patient's quality of life. Gene expression-based tests can accurately estimate the risk of recurrence in early stage breast cancers. Disease recurrence correlates with treatment resistance, creating a major need to resensitize tumors to treatment. Notch signaling is frequently deregulated in cancer and is involved in treatment resistance. Preclinical research has already identified many combinatory therapeutic options where Notch involvement enhances the effectiveness of radiotherapy, chemotherapy or targeted therapies for breast cancer. However, the benefit of targeting Notch has remained clinically inconclusive. In this review, we summarize the current knowledge on targeting the Notch pathway to enhance current treatments for breast cancer and to combat treatment resistance. Furthermore, we propose mechanisms to further exploit Notch-based therapeutics in the treatment of breast cancer.

SUBMITTER: Mollen EWJ 

PROVIDER: S-EPMC6256059 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6289793 | BioStudies
2018-01-01 | S-EPMC6139046 | BioStudies
2020-01-01 | S-EPMC7050132 | BioStudies
2020-01-01 | S-EPMC7212408 | BioStudies
2016-01-01 | S-EPMC4703529 | BioStudies
2020-01-01 | S-EPMC7565921 | BioStudies
2019-01-01 | S-EPMC6987401 | BioStudies
2020-01-20 | MODEL1912120005 | BioModels
1000-01-01 | S-EPMC4823058 | BioStudies
1000-01-01 | S-EPMC6272105 | BioStudies